Skip to content

Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age

Early Detection and Prevention of Health Complications in Premature Infants - Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07391527
Enrollment
210
Registered
2026-02-06
Start date
2025-09-23
Completion date
2027-02-28
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

5 Year Old Children Born Prematurely

Keywords

follow up of premature infants, early detection, developmental abnormality, Czech Republic

Brief summary

The project is a national, prospective, multicenter, interventional pilot project focused on the follow up of 5 year old children that were born prematurely. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of children born prematurely. This will minimize the negative impacts on the overall development of the child and the family of the prematurely born children.

Detailed description

The project is a national, prospective, multicenter, interventional pilot project focused on the follow up of 5 year old children that were born prematurely. The main goal of the project is establishing a methodology for the long-term monitoring of premature infants (in the area of developmental anomalies) and their evaluation at the age of 5 years. The main objective of this activity is to validate this screening process, which will benefit 210 patients in 2 perinatal and 2 intermediate centers. The child will undergo a comprehensive pediatric examination, including basic vision, speech, and psychomotoric assessments (MABC-2 and IDS-P). If any concerns are identified, the child will be referred to an appropriate specialist. The timeliness of this check-up has significant positive impact on both the patient and their family. The project is supported by the European Social Fund (Operational Program Employment plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22\_005/0002020. The study has been reviewed and approved by multiple local ethical committees. The listed IRB represents the lead national ethical committee overseeing the trial.

Interventions

OTHERPediatric check-up

Eligible children are invited to undergo a comprehensive pediatric evaluation, including vision screening (Plusoptix) and speech and language tests (TEPO - sentence comprehension, TEPRO - vocabulary production). Subsequently, children are referred for psychological (IDS-P), motor (MABC-2), and pulmonary (spirometry) assessments. If any deviations are identified, the child is referred to appropriate specialists (e.g., rehabilitation physician, speech therapist, psychiatrist, ophthalmologist).

Sponsors

Institute of Health Information and Statistics of the Czech Republic
Lead SponsorOTHER_GOV
České Budějovice Hospital
CollaboratorOTHER
General University Hospital, Prague
CollaboratorOTHER
Hospital Havlickuv Brod
CollaboratorUNKNOWN
County Hospital Liberec, Liberec
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* Signed consent for participation in the project and consent for the processing of personal data. * Children born before 37 weeks of gestation, aged 5 years, growing up in a Czech-speaking environment. * To ensure valid linkage of all data sources, the children must have been born to parents with Czech citizenship.

Exclusion criteria

* Unsigned consent for participation in the project and consent for the processing of personal data. * Severe psychomotor retardation . * Severe congenital malformations.

Design outcomes

Primary

MeasureTime frame
Proportion of premature infants with identified pathology at 5 years (overall, by detected pathology)During study participation (up to 3 days)
Proportion of premature infants referred to a specialized center (overall, by detected pathology)During study participation (up to 3 days)

Countries

Czechia

Contacts

CONTACTDaniela Dokoupilová, MSc
daniela.dokoupilova@uzis.cz+420725441408
CONTACTLucie Mandelová, Ph.D.
lucie.mandelova@uzis.cz+420770190828
STUDY_DIRECTORDaniela Marková, M.D.

General Hospital University in Prague

STUDY_DIRECTORRichard Plavka, prof.

General Hospital University in Prague

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026